Is Circulating Fibroblast Growth Factor 23 a Surrogate Marker or Active Mediator for the Construction of Atrial Fibrillation Substrate?

被引：1
|
作者：
Niwano, Shinichi [1 ]
机构：
[1] Kitasato Univ, Sch Med, Dept Cardiovasc Med, Sagamihara, Kanagawa 2520374, Japan
来源：
CIRCULATION JOURNAL | 2015年 / 79卷 / 08期
关键词：
CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; FGF23; KLOTHO; METABOLISM; MORTALITY; PHOSPHATE;
D O I：
10.1253/circj.CJ-15-0506
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1685 / 1686
页数：2
相关论文
共 50 条
  • [1] Is fibroblast growth factor 23 a player or a trigger in atrial fibrillation?
    Navarro-Garcia, Jose Alberto
    Wehrens, Xander H. T.
    Ruiz-Hurtado, Gema
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2025,
  • [2] Predictive value of circulating fibroblast growth factor-23 on atrial fibrillation: A meta-analysis
    Meng, Lei
    Yang, Yajuan
    Zhang, Zhiwei
    Li, Guangping
    Liu, Tong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 210 : 68 - 71
  • [3] Circulating Fibroblast Growth Factor-23 and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study
    Alonso, Alvaro
    Misialek, Jeffrey R.
    Eckfeldt, John H.
    Selvin, Elizabeth
    Coresh, Josef
    Chen, Lin Y.
    Soliman, Elsayed Z.
    Agarwal, Sunil K.
    Lutsey, Pamela L.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (05):
  • [4] Circulating Fibroblast Growth Factor 23 Has a U-Shaped Association With Atrial Fibrillation Prevalence
    Miyamura, Masatoshi
    Fujita, Shu-ichi
    Morita, Hideaki
    Sakane, Kazushi
    Okamoto, Yusuke
    Sohmiya, Koichi
    Hoshiga, Masaaki
    Ishizaka, Nobukazu
    CIRCULATION JOURNAL, 2015, 79 (08) : 1742 - 1748
  • [5] Fibroblast Growth Factor 23 A Novel Key to Find Hidden Substrates of Atrial Fibrillation?
    Kalyanasundaram, Anuradha
    Fedorov, Vadim V.
    CIRCULATION, 2014, 130 (04) : 295 - 297
  • [6] Fibroblast growth factor 23 and outcomes of atrial fibrillation: from clinical association to genetic evidence
    Li, Jiaju
    Lai, Yiwei
    Jiang, Chao
    Li, Mingxiao
    Yang, Zejun
    Zhao, Manlin
    Peng, Xiaodong
    Li, Sitong
    Li, Qifan
    Chen, Jiawei
    Wang, Zhen
    Zhang, Suhui
    Ma, Changsheng
    Dong, Jianzeng
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2025,
  • [7] Genetic Variants Associated with Circulating Fibroblast Growth Factor 23
    Robinson-Cohen, Cassianne
    Bartz, Traci M.
    Lai, Dongbing
    Ikizler, T. Alp
    Peacock, Munro
    Imel, Erik A.
    Michos, Erin D.
    Foroud, Tatiana M.
    Akesson, Kristina
    Taylor, Kent D.
    Malmgren, Linnea
    Matsushita, Kunihiro
    Nethander, Maria
    Eriksson, Joel
    Ohlsson, Claes
    Mellstrom, Daniel
    Wolf, Myles
    Ljunggren, Osten
    McGuigan, Fiona
    Rotter, Jerome I.
    Karlsson, Magnus
    Econs, Michael J.
    Ix, Joachim H.
    Lutsey, Pamela L.
    Psaty, Bruce M.
    de Boer, Ian H.
    Kestenbaum, Bryan R.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (10): : 2583 - 2592
  • [8] Fibroblast Growth Factor 23 Is a Promissing Marker of Myocardial Pathology
    Polvakova, V.
    Richter, M.
    Kubin, T.
    Walther, T.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S243 - S243
  • [9] Clinical significance of serum fibroblast growth factor 23 as a surrogate marker of the cardiorenal hemodynamic state in patients with heart failure
    Imazu, M.
    Takahama, H.
    Asanuma, H.
    Funada, A.
    Ohara, T.
    Hasegawa, T.
    Asakura, M.
    Kanzaki, H.
    Anzai, T.
    Kitakaze, M.
    EUROPEAN HEART JOURNAL, 2013, 34 : 781 - 782
  • [10] Lower soluble Klotho and higher fibroblast growth factor 23 serum levels are associated with episodes of atrial fibrillation
    Mizia-Stec, Katarzyna
    Wieczorek, Joanna
    Polak, Mateusz
    Wybraniec, Maciej T.
    Wozniak-Skowerska, Iwona
    Hoffmann, Andrzej
    Nowak, Seweryn
    Wikarek, Maria
    Wnuk-Wojnar, Anna
    Chudek, Jerzy
    Wiecek, Andrzej
    CYTOKINE, 2018, 111 : 106 - 111
12345